The goal of X-Change HF is to estimate the effect of biventricular stimulation in patients who need antibradycardia ventricular stimulation (more than 80%); are eligible for the exchange of an old pacemaker or implantable cardioverter defibrillator (ICD); and have ventricular dysfunction (left ventricular ejection fraction \[LVEF\] \< 35%). All patients eligible for participation in the study will be upgraded with a cardiac resynchronization therapy (CRT)-device and receive either right ventricular or biventricular stimulation in a crossover protocol. The endpoint is functional performance measured by spiroergometry.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Enrollment
36
Upgrade from ICD or pacemaker to CRT-D/CRT-P (Insync III, Insync Marquis, Insync Sentry, Insync Maximo, Concerto)
Klinikum Augsburg I. Medizinische Klinik
Augsburg, Germany
Charite Campus Virchow-Klinikum
Berlin, Germany
Unfallkrankenhaus Benjamin Franklin
Berlin, Germany
Ev. Freikirchliches KH Bernau und Herzzentrum Brandenburg
Bernau, Germany
Berufsgenossenschaftliche Kliniken Bergmannsheil
Bochum, Germany
Städtisches Kreiskrankenhaus
Friedrichshafen, Germany
Georg-August-Universität Göttingen
Göttingen, Germany
St.-Vincentius Klinken
Karlsruhe, Germany
Märkische Kliniken GmbH Klinikum Luedenscheid
Lüdenscheid, Germany
Krankenhaus Reinbek St. Adolf Stift
Reinbek B. Hamburg, Germany
Cardiopulmonary performance measured by spiroergometry
Maximal oxygen uptake (Vo2 max \[ml/kg/min\])
Time frame: Baseline to 7 months post-implant
Left ventricular end diastolic diameter (LVEDD [mm])
Time frame: Baseline to 7 months post-implant
N-terminal prohormone brain natriuretic peptide (NT-proBNP) [pg/ml]
Time frame: Baseline to 7 months post-implant
Left ventricular ejection fraction (LVEF [%])
Time frame: Baseline to 7 months post-implant
New York Heart Association (NYHA) Class
Time frame: Baseline to 7 months post-implant
Occurrence of rhythm disturbances: atrial arrhythmias (amount and duration [h/day])
Time frame: Baseline to 7 months post-implant
Occurrence of rhythm disturbances: ventricular arrhythmias (amount and duration [h/day])
Time frame: Baseline to 7 months post-implant
Heart rate variability [ms]
Time frame: Baseline to 7 months post implant
Amount of hospitalizations because of heart failure (amount and duration [days])
Time frame: Baseline to 7 months post-implant
Cardiopulmonary performance measured by spiroergometry: Oxygen uptake at the anaerobic threshold (VO2 AT [s])
Time frame: Baseline to 7 months post-implant
Mortality
Time frame: Baseline to 7 months post-implant
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.